Biotech Companies That Focus On Mental Health

Published on

ATAI Life Sciences joined the mental health market in 2018 but is already working on various compounds for depression, anxiety, addiction, etc. Their research is based on psychedelics, but they are now also involved in the digital health space. IntroSpect is a digital platform of ATAI Life Sciences where they leverage flexibility and technology to meet their patient’s requirements.

Published on Biotech Companies, Bright Minds, Bright Minds Bio, Bright Minds Biosciences, Mental Health

To be informed of the latest articles, subscribe:
You might also like:
Have A Brighter Tomorrow With Bright Minds
Have A Brighter Tomorrow With Bright Minds
A Canadian Psychedelic Company and a Biotechnology Company
A Canadian Psychedelic Company and a Biotechnology Company
Challenges Faced By the Biotech Industry
Challenges Faced By the Biotech Industry
How The Bright Minds Biosciences Help To Reduces Mental Disorder?
How The Bright Minds Biosciences Help To Reduces Mental Disorder?
Top Canadian Psychedelic Company Stocks to Watch
Canada's Psychedelic Future
Comment on this post